SEC Fines MusclePharm For Unreported Executive Perks, Disclosure Gaps
This article was originally published in The Tan Sheet
Executive Summary
The firm, which recently appointed a board chairman as founder and CEO Brad Pyatt moved out of the post in a restructuring, agrees to a $700,000 fine and to make management changes including hiring an independent monitor for one year.